CYP51A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.255600E-01
Normal-vs-Stage2
2.865000E-01
Normal-vs-Stage3
9.556400E-01
Normal-vs-Stage4
3.531200E-01
Stage1-vs-Stage2
6.108000E-01
Stage1-vs-Stage3
3.627800E-01
Stage1-vs-Stage4
4.849800E-01
Stage2-vs-Stage3
1.967840E-01
Stage2-vs-Stage4
6.233800E-01
Stage3-vs-Stage4
2.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.935600E-01
Normal-vs-AfricanAmerican
1.720770E-01
Normal-vs-Asian
3.829200E-01
Caucasian-vs-AfricanAmerican
7.309400E-01
Caucasian-vs-Asian
4.778800E-01
AfricanAmerican-vs-Asian
4.279600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.690800E-01
Normal-vs-Female
3.503000E-01
Male-vs-Female
1.773970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.329200E-01
Normal-vs-Age(41-60Yrs)
2.990000E-01
Normal-vs-Age(61-80Yrs)
3.041200E-01
Normal-vs-Age(81-100Yrs)
2.634000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.238800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.647000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.402800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.165000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.334400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.579400E-01
Normal-vs-Daily Drinker
3.158400E-01
Normal-vs-Weekly Drinker
4.189400E-01
Normal-vs-Occasional Drinker
2.041600E-01
Normal-vs-Social Drinker
2.100800E-01
Non Drinker-vs-Daily Drinker
3.910400E-01
Non Drinker-vs-Weekly Drinker
2.830800E-01
Non Drinker-vs-Occasional Drinker
5.713800E-01
Non Drinker-vs-Social Drinker
8.089200E-01
Daily Drinker-vs-Weekly Drinker
7.340600E-01
Daily Drinker-vs-Occasional Drinker
7.068600E-01
Daily Drinker-vs-Social Drinker
5.000400E-01
Weekly Drinker-vs-Occasional Drinker
4.917000E-01
Weekly Drinker-vs-Social Drinker
3.629200E-01
Occasional Drinker-vs-Social Drinker
7.308000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.363800E-02
Normal-vs-Grade 2
7.475800E-02
Normal-vs-Grade 3
3.528200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.579600E-01
Grade 1-vs-Grade 3
8.440600E-01
Grade 1-vs-Grade 4
3.363800E-02
Grade 2-vs-Grade 3
2.083200E-01
Grade 2-vs-Grade 4
7.475800E-02
Grade 3-vs-Grade 4
3.528200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.713400E-01
Normal-vs-NonDiabetic
2.616400E-01
Diabetic-vs-NonDiabetic
1.827980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.434600E-01
Normal-vs-NoPancreatitis
2.958600E-01
Pancreatitis-vs-NoPancreatitis
7.283600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.901800E-01
Normal-vs-N1
2.936400E-01
N0-vs-N1
9.484200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.110200E-01
Normal-vs-TP53-NonMutant
3.058200E-01
TP53-Mutant-vs-TP53-NonMutant
2.873200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
